目次

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning

2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis

3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ billion)
Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global Cancer Immunotherapy Market 2018 - 2022
Historic Market Size - Data Table on Global Cancer Immunotherapy Market 2018 - 2022 ($ billion)
4.2 Type segment analysis 2018 - 2022
Historic Market Size - Type Segment 2018 - 2022 ($ billion)
4.3 Application segment analysis 2018 - 2022
Historic Market Size - Application Segment 2018 - 2022 ($ billion)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type
6.1 Market segments
Chart on Type - Market share 2023-2028 (%)
Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
6.3 Monoclonal antibodies - Market size and forecast 2023-2028
Chart on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion)
Data Table on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion)
Chart on Monoclonal antibodies - Year-over-year growth 2023-2028 (%)
Data Table on Monoclonal antibodies - Year-over-year growth 2023-2028 (%)
6.4 Check point inhibitors and immunomodulators - Market size and forecast 2023-2028
Chart on Check point inhibitors and immunomodulators - Market size and forecast 2023-2028 ($ billion)
Data Table on Check point inhibitors and immunomodulators - Market size and forecast 2023-2028 ($ billion)
Chart on Check point inhibitors and immunomodulators - Year-over-year growth 2023-2028 (%)
Data Table on Check point inhibitors and immunomodulators - Year-over-year growth 2023-2028 (%)
6.5 Cancer vaccines - Market size and forecast 2023-2028
Chart on Cancer vaccines - Market size and forecast 2023-2028 ($ billion)
Data Table on Cancer vaccines - Market size and forecast 2023-2028 ($ billion)
Chart on Cancer vaccines - Year-over-year growth 2023-2028 (%)
Data Table on Cancer vaccines - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Type
Market opportunity by Type ($ billion)
Data Table on Market opportunity by Type ($ billion)

7 Market Segmentation by Application
7.1 Market segments
Chart on Application - Market share 2023-2028 (%)
Data Table on Application - Market share 2023-2028 (%)
7.2 Comparison by Application
Chart on Comparison by Application
Data Table on Comparison by Application
7.3 Lung cancer - Market size and forecast 2023-2028
Chart on Lung cancer - Market size and forecast 2023-2028 ($ billion)
Data Table on Lung cancer - Market size and forecast 2023-2028 ($ billion)
Chart on Lung cancer - Year-over-year growth 2023-2028 (%)
Data Table on Lung cancer - Year-over-year growth 2023-2028 (%)
7.4 Breast cancer - Market size and forecast 2023-2028
Chart on Breast cancer - Market size and forecast 2023-2028 ($ billion)
Data Table on Breast cancer - Market size and forecast 2023-2028 ($ billion)
Chart on Breast cancer - Year-over-year growth 2023-2028 (%)
Data Table on Breast cancer - Year-over-year growth 2023-2028 (%)
7.5 Colorectal cancer - Market size and forecast 2023-2028
Chart on Colorectal cancer - Market size and forecast 2023-2028 ($ billion)
Data Table on Colorectal cancer - Market size and forecast 2023-2028 ($ billion)
Chart on Colorectal cancer - Year-over-year growth 2023-2028 (%)
Data Table on Colorectal cancer - Year-over-year growth 2023-2028 (%)
7.6 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ billion)
Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
7.7 Market opportunity by Application
Market opportunity by Application ($ billion)
Data Table on Market opportunity by Application ($ billion)

8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ billion)
Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ billion)
Data Table on US - Market size and forecast 2023-2028 ($ billion)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ billion)
Data Table on China - Market size and forecast 2023-2028 ($ billion)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.10 France - Market size and forecast 2023-2028
Chart on France - Market size and forecast 2023-2028 ($ billion)
Data Table on France - Market size and forecast 2023-2028 ($ billion)
Chart on France - Year-over-year growth 2023-2028 (%)
Data Table on France - Year-over-year growth 2023-2028 (%)
9.11 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ billion)
Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints

11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business

12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 Amgen Inc.
Amgen Inc. - Overview
Amgen Inc. - Product / Service
Amgen Inc. - Key news
Amgen Inc. - Key offerings
12.4 AstraZeneca Plc
AstraZeneca Plc - Overview
AstraZeneca Plc - Product / Service
AstraZeneca Plc - Key news
AstraZeneca Plc - Key offerings
12.5 Bayer AG
Bayer AG - Overview
Bayer AG - Business segments
Bayer AG - Key news
Bayer AG - Key offerings
Bayer AG - Segment focus
12.6 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
12.7 Eli Lilly and Co.
Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product / Service
Eli Lilly and Co. - Key news
Eli Lilly and Co. - Key offerings
12.8 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
12.9 Gilead Sciences Inc.
Gilead Sciences Inc. - Overview
Gilead Sciences Inc. - Product / Service
Gilead Sciences Inc. - Key news
Gilead Sciences Inc. - Key offerings
12.10 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
12.11 Immunocore Holdings Plc
Immunocore Holdings Plc - Overview
Immunocore Holdings Plc - Product / Service
Immunocore Holdings Plc - Key news
Immunocore Holdings Plc - Key offerings
12.12 Johnson and Johnson Services Inc.
Johnson and Johnson Services Inc. - Overview
Johnson and Johnson Services Inc. - Business segments
Johnson and Johnson Services Inc. - Key news
Johnson and Johnson Services Inc. - Key offerings
Johnson and Johnson Services Inc. - Segment focus
12.13 Merck KGaA
Merck KGaA - Overview
Merck KGaA - Business segments
Merck KGaA - Key news
Merck KGaA - Key offerings
Merck KGaA - Segment focus
12.14 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
12.15 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
12.16 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
12.17 Takeda Pharmaceutical Co. Ltd.
Takeda Pharmaceutical Co. Ltd. - Overview
Takeda Pharmaceutical Co. Ltd. - Product / Service
Takeda Pharmaceutical Co. Ltd. - Key news
Takeda Pharmaceutical Co. Ltd. - Key offerings

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Application
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Parent Market
Exhibits11: Data Table on - Parent Market
Exhibits12: Market characteristics analysis
Exhibits13: Value Chain Analysis
Exhibits14: Offerings of companies included in the market definition
Exhibits15: Market segments
Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits20: Historic Market Size - Data Table on Global Cancer Immunotherapy Market 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits25: Five forces analysis - Comparison between 2023 and 2028
Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits31: Chart on Market condition - Five forces 2023 and 2028
Exhibits32: Chart on Type - Market share 2023-2028 (%)
Exhibits33: Data Table on Type - Market share 2023-2028 (%)
Exhibits34: Chart on Comparison by Type
Exhibits35: Data Table on Comparison by Type
Exhibits36: Chart on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion)
Exhibits37: Data Table on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion)
Exhibits38: Chart on Monoclonal antibodies - Year-over-year growth 2023-2028 (%)
Exhibits39: Data Table on Monoclonal antibodies - Year-over-year growth 2023-2028 (%)
Exhibits40: Chart on Check point inhibitors and immunomodulators - Market size and forecast 2023-2028 ($ billion)
Exhibits41: Data Table on Check point inhibitors and immunomodulators - Market size and forecast 2023-2028 ($ billion)
Exhibits42: Chart on Check point inhibitors and immunomodulators - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on Check point inhibitors and immunomodulators - Year-over-year growth 2023-2028 (%)
Exhibits44: Chart on Cancer vaccines - Market size and forecast 2023-2028 ($ billion)
Exhibits45: Data Table on Cancer vaccines - Market size and forecast 2023-2028 ($ billion)
Exhibits46: Chart on Cancer vaccines - Year-over-year growth 2023-2028 (%)
Exhibits47: Data Table on Cancer vaccines - Year-over-year growth 2023-2028 (%)
Exhibits48: Market opportunity by Type ($ billion)
Exhibits49: Data Table on Market opportunity by Type ($ billion)
Exhibits50: Chart on Application - Market share 2023-2028 (%)
Exhibits51: Data Table on Application - Market share 2023-2028 (%)
Exhibits52: Chart on Comparison by Application
Exhibits53: Data Table on Comparison by Application
Exhibits54: Chart on Lung cancer - Market size and forecast 2023-2028 ($ billion)
Exhibits55: Data Table on Lung cancer - Market size and forecast 2023-2028 ($ billion)
Exhibits56: Chart on Lung cancer - Year-over-year growth 2023-2028 (%)
Exhibits57: Data Table on Lung cancer - Year-over-year growth 2023-2028 (%)
Exhibits58: Chart on Breast cancer - Market size and forecast 2023-2028 ($ billion)
Exhibits59: Data Table on Breast cancer - Market size and forecast 2023-2028 ($ billion)
Exhibits60: Chart on Breast cancer - Year-over-year growth 2023-2028 (%)
Exhibits61: Data Table on Breast cancer - Year-over-year growth 2023-2028 (%)
Exhibits62: Chart on Colorectal cancer - Market size and forecast 2023-2028 ($ billion)
Exhibits63: Data Table on Colorectal cancer - Market size and forecast 2023-2028 ($ billion)
Exhibits64: Chart on Colorectal cancer - Year-over-year growth 2023-2028 (%)
Exhibits65: Data Table on Colorectal cancer - Year-over-year growth 2023-2028 (%)
Exhibits66: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits67: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits68: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits69: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits70: Market opportunity by Application ($ billion)
Exhibits71: Data Table on Market opportunity by Application ($ billion)
Exhibits72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits73: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits74: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits75: Chart on Geographic comparison
Exhibits76: Data Table on Geographic comparison
Exhibits77: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits78: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits79: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits82: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits83: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits86: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits87: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits90: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits91: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits94: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits95: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits98: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits99: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits101: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits102: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits103: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits104: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits105: Chart on France - Market size and forecast 2023-2028 ($ billion)
Exhibits106: Data Table on France - Market size and forecast 2023-2028 ($ billion)
Exhibits107: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits108: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits109: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits110: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits111: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits112: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits113: Market opportunity By Geographical Landscape ($ billion)
Exhibits114: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits115: Impact of drivers and challenges in 2023 and 2028
Exhibits116: Overview on criticality of inputs and factors of differentiation
Exhibits117: Overview on factors of disruption
Exhibits118: Impact of key risks on business
Exhibits119: Companies covered
Exhibits120: Matrix on companies position and classification
Exhibits121: Amgen Inc. - Overview
Exhibits122: Amgen Inc. - Product / Service
Exhibits123: Amgen Inc. - Key news
Exhibits124: Amgen Inc. - Key offerings
Exhibits125: AstraZeneca Plc - Overview
Exhibits126: AstraZeneca Plc - Product / Service
Exhibits127: AstraZeneca Plc - Key news
Exhibits128: AstraZeneca Plc - Key offerings
Exhibits129: Bayer AG - Overview
Exhibits130: Bayer AG - Business segments
Exhibits131: Bayer AG - Key news
Exhibits132: Bayer AG - Key offerings
Exhibits133: Bayer AG - Segment focus
Exhibits134: Bristol Myers Squibb Co. - Overview
Exhibits135: Bristol Myers Squibb Co. - Product / Service
Exhibits136: Bristol Myers Squibb Co. - Key news
Exhibits137: Bristol Myers Squibb Co. - Key offerings
Exhibits138: Eli Lilly and Co. - Overview
Exhibits139: Eli Lilly and Co. - Product / Service
Exhibits140: Eli Lilly and Co. - Key news
Exhibits141: Eli Lilly and Co. - Key offerings
Exhibits142: F. Hoffmann La Roche Ltd. - Overview
Exhibits143: F. Hoffmann La Roche Ltd. - Business segments
Exhibits144: F. Hoffmann La Roche Ltd. - Key news
Exhibits145: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits146: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits147: Gilead Sciences Inc. - Overview
Exhibits148: Gilead Sciences Inc. - Product / Service
Exhibits149: Gilead Sciences Inc. - Key news
Exhibits150: Gilead Sciences Inc. - Key offerings
Exhibits151: GlaxoSmithKline Plc - Overview
Exhibits152: GlaxoSmithKline Plc - Business segments
Exhibits153: GlaxoSmithKline Plc - Key news
Exhibits154: GlaxoSmithKline Plc - Key offerings
Exhibits155: GlaxoSmithKline Plc - Segment focus
Exhibits156: Immunocore Holdings Plc - Overview
Exhibits157: Immunocore Holdings Plc - Product / Service
Exhibits158: Immunocore Holdings Plc - Key news
Exhibits159: Immunocore Holdings Plc - Key offerings
Exhibits160: Johnson and Johnson Services Inc. - Overview
Exhibits161: Johnson and Johnson Services Inc. - Business segments
Exhibits162: Johnson and Johnson Services Inc. - Key news
Exhibits163: Johnson and Johnson Services Inc. - Key offerings
Exhibits164: Johnson and Johnson Services Inc. - Segment focus
Exhibits165: Merck KGaA - Overview
Exhibits166: Merck KGaA - Business segments
Exhibits167: Merck KGaA - Key news
Exhibits168: Merck KGaA - Key offerings
Exhibits169: Merck KGaA - Segment focus
Exhibits170: Novartis AG - Overview
Exhibits171: Novartis AG - Business segments
Exhibits172: Novartis AG - Key news
Exhibits173: Novartis AG - Key offerings
Exhibits174: Novartis AG - Segment focus
Exhibits175: Pfizer Inc. - Overview
Exhibits176: Pfizer Inc. - Product / Service
Exhibits177: Pfizer Inc. - Key news
Exhibits178: Pfizer Inc. - Key offerings
Exhibits179: Sanofi SA - Overview
Exhibits180: Sanofi SA - Business segments
Exhibits181: Sanofi SA - Key news
Exhibits182: Sanofi SA - Key offerings
Exhibits183: Sanofi SA - Segment focus
Exhibits184: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits185: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits186: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits187: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits188: Inclusions checklist
Exhibits189: Exclusions checklist
Exhibits190: Currency conversion rates for US$
Exhibits191: Research methodology
Exhibits192: Information sources
Exhibits193: Data validation
Exhibits194: Validation techniques employed for market sizing
Exhibits195: Data synthesis
Exhibits196: 360 degree market analysis
Exhibits197: List of abbreviations